Palomar, Johnson & Johnson to Develop Home-Use Light Devices
BURLINGTON, Mass., Sept. 7 -- Palomar Medical Technologies Inc. said today it has signed an agreement with Johnson & Johnson Consumer Companies Inc. (JJCC), a Johnson & Johnson company, to develop "light-based devices for reducing or reshaping body fat including cellulite, for reducing signs of aging skin and for reducing or preventing acne." Under the agreement, JJCC will fund Palomar's development and clinical studies during an initial proof-of-principle phase.
Palomar CEO Joseph P. Caruso said the deal enables Palomar to continue early-stage research and development of light-based technology in a variety of fields for introduction to the consumer market. The agreement provides for continued research and development of light-based technology and possible product commercialization, if testing and regulatory requirements are met. Details are in a corresponding filing with the Securities and Exchange Commission.
In June, Palomar and The Gillette Company announced they had completed the initial phase of their joint development of a home-use, light-based hair removal device. The original agreement provided for $7 million in development funding from Gillette, which is providing $2.1 million in additional funding over a 9-month extension of the development phase, planned to be completed by August 31, 2006.
For more information, visit: www.palomarmedical.com
LATEST NEWS
- Himax Invests in, Collaborates with Fiber Interconnect Specialist FOCI
Jun 12, 2024
- Sheba Adds Senior Strategic Advisor: People in the News: 6/12/24
Jun 12, 2024
- Photonic Insulator Offers Platform for Study of Light-Matter Interaction
Jun 11, 2024
- Erbium Laser Miniaturized to Chip-Scale
Jun 11, 2024
- Chip-Based 3D Printer for Prototyping on the Go
Jun 10, 2024
- Omega Optical Names CEO
Jun 10, 2024
- Quantinuum Launches 56-Qubit Quantum Computer: Week in Brief: 6/7/2024
Jun 7, 2024
- Atom Computing Lands Investment, Expands Overseas
Jun 7, 2024